{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:03:53Z","timestamp":1793516633076,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jconrel.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T22:42:23Z","timestamp":1721774543000},"page":"385-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"373","author":[{"given":"Yifu","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qindai","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.07.011_bb0005","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41591-023-02602-2","article-title":"An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Kendall","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0010","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH) - a review of a crowded clinical landscape, Driven by a Complex Disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated Steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.30215","article-title":"Macrophage-specific hypoxia-inducible factor-1\u03b1 contributes to impaired Autophagic flux in nonalcoholic steatohepatitis","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of Cancer chronic inflammation through HIF-1 and NF-\u03baB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0030","doi-asserted-by":"crossref","first-page":"24171","DOI":"10.1074\/jbc.M604507200","article-title":"Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbrc.2018.03.110","article-title":"PPAR\u03b3 alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2\/STAT3 pathway","volume":"498","author":"Bi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0045","first-page":"783","article-title":"Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease, expert rev","volume":"15","author":"Carranza-Trejo","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0050","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","article-title":"Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease","volume":"11","author":"Cairoli","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1165\/rcmb.2020-0492OC","article-title":"Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver disease","volume":"65","author":"Mesarwi","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6764","article-title":"Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy","volume":"6","author":"Xin","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0065","series-title":"Action Sites and Clinical Application of HIF-1\u03b1 Inhibitors, Molecules (Basel, Switzerland)","first-page":"27","author":"Xu","year":"2022"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0070","doi-asserted-by":"crossref","first-page":"eaba9112","DOI":"10.1126\/scitranslmed.aba9112","article-title":"HIF-1\u03b1 inhibitor PX-478 preserves pancreatic \u03b2 cell function in diabetes","volume":"14","author":"Ilegems","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-019-0752-z","article-title":"Status of current clinical development","volume":"21","author":"Fallah","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0090","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/acsptsci.3c00210","article-title":"Liposome-based Silibinin for mitigating nonalcoholic fatty liver disease: dual effects via parenteral and intestinal routes","volume":"6","author":"Yan","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0095","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0100","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","article-title":"Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E\/low density lipoprotein receptor and the N-acetyl-d-galactosamine\/asialoglycoprotein receptor pathway","volume":"322","author":"Sato","year":"2020","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","article-title":"Strategies for non-viral vectors targeting organs beyond the liver","volume":"19","author":"Kim","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0115","doi-asserted-by":"crossref","first-page":"20220045","DOI":"10.1002\/EXP.20220045","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0120","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/BJ20111377","article-title":"Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia","volume":"441","author":"Shen","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/acs.accounts.0c00413","article-title":"Nano-bio interactions in Cancer: from therapeutics delivery to early detection","volume":"54","author":"Liu","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1515\/znc-2001-7-826","article-title":"Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites","volume":"56","author":"Boll","year":"2001","journal-title":"Z Naturforsch C J Biosci"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122743","article-title":"Changes in disposition of ezetimibe and its active metabolites induced by impaired hepatic function: the influence of enzyme and transporter activities","volume":"14","author":"Xie","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124620","article-title":"Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport","volume":"4","author":"Morton","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"Journal of Controlled Release : Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.21037\/atm-21-4222","article-title":"Regulatory mechanism of HIF-1\u03b1 and its role in liver diseases: a narrative review","volume":"10","author":"Chu","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.207","article-title":"Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression","volume":"49","author":"Lee","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0180","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12967-021-02854-x","article-title":"The roles and mechanisms of hypoxia in liver fibrosis","volume":"19","author":"Cai","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-019-03672-y","article-title":"Hypoxia induces the activation of hepatic stellate cells through the PVT1-miR-152-ATG14 signaling pathway","volume":"465","author":"Yu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4132\/jptm.2020.03.07","article-title":"A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy","volume":"54","author":"Lee","year":"2020","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13287-022-02929-6","article-title":"The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles","volume":"13","author":"Moayedfard","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41577-023-00857-x","article-title":"Splenic stromal niches in homeostasis and immunity","volume":"23","author":"Alexandre","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s43856-024-00465-3","article-title":"Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human","volume":"4","author":"Tsouka","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0220","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41467-023-39768-9","article-title":"Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41419-020-2571-4","article-title":"Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease","volume":"11","author":"Woitok","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.07.011_bb0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2023.10.035","article-title":"Disease-specific corona mediated co-delivery of MTX and siRNA-TNF\u03b1 by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis","volume":"364","author":"Xin","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00125-015-3825-z","article-title":"G protein-coupled receptors as new therapeutic targets for type 2 diabetes","volume":"59","author":"Reimann","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","article-title":"Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity","volume":"8","author":"Zhu","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jconrel.2024.07.011_bb0250","first-page":"228","article-title":"Hepato-splenic axis: hepatic and splenic metabolic activities are linked","volume":"8","author":"Keramida","year":"2018","journal-title":"Am. J. Nucl. Med. Mol. Imaging"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T16:53:08Z","timestamp":1725727988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"alternative-id":["S0168365924004425"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}